Receptor
From Proteopedia
(Difference between revisions)
Line 135: | Line 135: | ||
==Nuclear receptors== | ==Nuclear receptors== | ||
*[[Nuclear receptors]] | *[[Nuclear receptors]] | ||
+ | *[[Thyroid hormone receptor]] | ||
+ | *[[Retinoic acid receptor]] | ||
+ | *[[RA Mediated T-reg Differentiation]]; Retinoic acid acts as the ligand for the Retinoic Acid Receptor-α (RARα) / Retinoid X Receptor-α (RXRα) heterodimer | ||
+ | * [[PPAR-gamma]] | ||
+ | * [[Pioglitazone]] is a selective agonist for Peroxisome Proliferator-Activated Receptor Gamma | ||
+ | *[[Liver X receptor]] | ||
+ | *[[Bile acid receptor]] | ||
+ | *[[Vitamin D receptor]] | ||
+ | *[[Pregnane X receptor]] | ||
+ | *[[Retinoid X receptor]] | ||
+ | *[[Estrogen receptor]] | ||
+ | *[[Ivan Koutsopatriy estrogen receptor]] | ||
+ | * [[Estrogen receptor#Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of SERMs]] <ref>PMID: 21473635</ref> | ||
+ | * [[Estrogen receptor#Estrogen receptor α complexed with raloxifene and a corepressor peptide]] | ||
+ | * [[Tamoxifen|Tamoxifen and the Estrogen receptor]] | ||
+ | * [[Student Project 10 for UMass Chemistry 423 Spring 2015]] | ||
+ | *[[Estrogen-related receptor]] | ||
+ | *[[Glucocorticoid receptor]] | ||
+ | *[[Mineralocorticoid receptor]] | ||
+ | *[[Progesterone receptor]] | ||
+ | *[[Androgen receptor]] | ||
+ | *[[Liver receptor homolog-1]]? | ||
==Endoplasmic reticulum/Sarcoplasmic reticulum receptors== | ==Endoplasmic reticulum/Sarcoplasmic reticulum receptors== |
Revision as of 08:30, 11 April 2021
|
References
- ↑ De Rienzo F, Moura Barbosa AJ, Perez MA, Fernandes PA, Ramos MJ, Menziani MC. The extracellular subunit interface of the 5-HT(3) receptors: a computational alanine scanning mutagenesis study. J Biomol Struct Dyn. 2012 Jul;30(3):280-98. Epub 2012 Jun 12. PMID:22694192 doi:10.1080/07391102.2012.680029
- ↑ Segaliny AI, Tellez-Gabriel M, Heymann MF, Heymann D. Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers. J Bone Oncol. 2015 Jan 23;4(1):1-12. doi: 10.1016/j.jbo.2015.01.001. eCollection , 2015 Mar. PMID:26579483 doi:http://dx.doi.org/10.1016/j.jbo.2015.01.001
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y